 The primary purpose of this study is to evaluate the induction potential of repeated administration of intranasal esketamine on cytochrome P450 CYP 3A4 and CYP2B6 activity in healthy participants using orally administered midazolam and bupropion as probes, respectively and to evaluate the pharmacokinetics of esketamine after a single dose and repeated administration. 